About Hankang
- 分類：漢康集團
- 發(fā)布時間：2023-10-23 11:44:45
- 訪問量：0
Hankang Pharmaceutical Group, established in 1999, is a renowned integrated CRO-CDMO service enterprise in China. With a foundation in generic drugs and an outlook
towards innovative pharmaceuticals, the group is committed to being a provider of
comprehensive, systematic solutions for new drug development, a solver of diverse
customer service needs, a practitioner in reducing research and development costs while
enhancing efficiency, and a believer in improving human health.
With over two decades of development, Hankang has a workforce of over a thousand
employees nationwide. It has developed more than 200 varieties for over 600 domestic
and international companies, having served in the development of more than 10 innovative
drugs, successfully created more than 10 first-to-market generic drugs, contributed to over 20
top-ranked domestic products, and achieved more than 30 products with a production value
exceeding one billion RMB. The group has established over 10 platforms for innovative formulation
and active pharmaceutical ingredient development, with a presence in North, Central, East,
and South China, effectively establishing its footprint in pharmaceutical research and development,
formulation, and API production, providing a solid foundation for offering a fully integrated,
one-stop service to pharmaceutical companies worldwide.
Leveraging its robust research and development capabilities, Hankang has been recognized
as a national-level "Enterprise Technology Center." It has also undertaken numerous national
and provincial-level projects, earning the title of "China Innovative CRO Enterprise" from the
Ministry of Industry and Information Technology. Hankang has consistently ranked among the
top three in the National Federation of Industry and Commerce's selection of the "Top 50
Chinese Pharmaceutical Research and Development Enterprises" and has received a National
Science and Technology Achievement Award. In 2019, Hankang was approved by the Ministry
of Human Resources and Social Security and the National Postdoctoral Management Committee
to establish a postdoctoral research workstation, serving as an excellent platform for nurturing
and developing pharmaceutical research talents. In the future, Hankang will contribute even more
to the high-quality development of China's pharmaceutical industry and the well-being of its people.
TEL:86-022-23020968
聯(lián)系方式
商務/營銷合作：[email protected]
原料藥合作：[email protected]
APl: [email protected]
原料藥事業(yè)部(API)聯(lián)系電話：86-022-23020968
公眾號
歡迎關注我們的官方公眾號
留言反饋